The trial included over 13,000 people across 30 countries and ran for more than 4.5 years, making it the largest and longest study on tirzepatide so far, the company said ...

Researchers who have developed a new "heart age" calculator say many Americans have unhealthy hearts that are physiologically ...

For some patients in Riverside and San Bernardino counties, traveling considerable distances is part of the everyday concerns ...

Governor releases list of impacts Trump Administration’s budget will have on Wisconsin’s seniors, women, veterans, people ...

Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...

The federal government has reaffirmed its commitment to preventing disruption in Nigeria’s health sector, assuring the public that it is actively engaging with unions and professional associations to ...

Hugh Chatham Health has received the American Heart Association’s Get With The Guidelines — Stroke Gold Plus quality ...

The fast-selling GLP-1 drug matched Lilly's older medicine Trulicity in a closely watched cardiovascular outcomes trial, ...

Knowing the current health status of your heart is crucial - and dating your heart's age might just be the right tool for it.

CHI Memorial is proud to announce it is the first hospital in the world to enroll a patient in a Phase 3 clinical trial evaluating a promising new treatment for ischemic stroke. This groundbreaking ...

St. Rita’s Medical Center has received the American Heart Association’s Get With The Guidelines® - Stroke Gold Plus quality ...

SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.